Скачать или смотреть Q&A: HIV-related mortality among children and adolescents on antiretroviral therapy

A new analysis published in The Lancet HIV examined HIV-related mortality among children and adolescents (aged 0 to 14 years) who have received antiretroviral therapy (ART). Mortality decreased between 2000 and 2020 globally, after adjusting for region, baseline CD4 cell count (an indicator of the strength of the immune system), age, treatment duration, and sex.

However, the mortality risk remains highest among the youngest children, especially those under one year of age, as well as for children who started ART treatment late at low CD4 counts, and within the first six months after initiating it. Dr. Hmwe Kyu, Associate Professor at IHME, presents findings from this analysis.

Read the transcript: https://www.healthdata.org/news-event...

An independent population health research organization based at the University of Washington School of Medicine, the Institute for Health Metrics and Evaluation (IHME) works with collaborators around the world to develop timely, relevant, and scientifically valid evidence that illuminates the state of health everywhere. https://www.healthdata.org/

Where to follow us:
•   / institute-for-health-metrics-and-evaluation  
•   / ihme_uw  
•   / ihmeuw